Broadcom named strategic vendor for Walmart virtualization solutions
Investing.com - Pharvaris BV reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Pharvaris BV announced earnings per share of €-0.38 on revenue of €0.00. Analysts polled by Investing.com EPS of €-0.5654 on revenue of €0.00.
Pharvaris BV 's are down 35% and is trading at €9.31 , still down 66.15% from its 52 week high of €27.50 set on Friday, June 17, 2022.
Pharvaris BV shares gained 0.59% to trade at €9.31 in intra-day trade the report.
Pharvaris BV follows other major Healthcare sector earnings this month
Pharvaris BV's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of €1.13 on revenue of €7.37B, EPS of €1.12 on revenue of €7.22B.
Merck ADR had beat expectations on Friday with third quarter EPS of €0.5392 on revenue of €5.69B, for EPS of €0.5165 on revenue of €5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar